Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED SCHEDULE OF INVESTMENTS (Parenthetical)

v3.24.0.1
CONSOLIDATED SCHEDULE OF INVESTMENTS (Parenthetical)
$ in Thousands
Dec. 31, 2023
USD ($)
Firm
Dec. 31, 2022
USD ($)
Firm
Summary of Investment Holdings    
Investment, basis spread, variable rate 8.50%  
Tax basis of investments, gross, unrealized appreciation $ 118,300 $ 72,200
Tax basis of investments, gross, unrealized depreciation 115,900 112,000
Tax basis of investments, unrealized appreciation (depreciation), net 2,400 (39,800)
Tax basis of investments, cost for income tax purposes 3,200,000 3,000,000
Investment cost 3,247,033 3,005,696
Investments, at fair value: 3,248,046 2,963,955
Black Crow AI, Inc. | Promissory Notes    
Summary of Investment Holdings    
Principal amount 2,400 3,000
Phathom Pharmaceuticals, Inc. | Royalty Contract    
Summary of Investment Holdings    
Investment cost 12,000 4,600
Investments, at fair value: $ 9,400 $ 3,400
Quoted Prices in Active Markets for Identical Assets (Level 1) | Warrants    
Summary of Investment Holdings    
Number of publicly traded companies | Firm 24 27
Quoted Prices in Active Markets for Identical Assets (Level 1) | Common Stock    
Summary of Investment Holdings    
Number of publicly traded companies | Firm 36 43
PRIME    
Summary of Investment Holdings    
Investment, basis spread, variable rate   7.50%
1-month SOFR    
Summary of Investment Holdings    
Interest rate 5.34%  
3-month SOFR    
Summary of Investment Holdings    
Interest rate 5.36%  
6-month SOFR    
Summary of Investment Holdings    
Interest rate 5.35%  
1-month LIBOR    
Summary of Investment Holdings    
Interest rate   4.40%
3-month LIBOR    
Summary of Investment Holdings    
Interest rate   4.77%
6-month LIBOR    
Summary of Investment Holdings    
Interest rate   5.14%